Código QR (código de barras bidimensional)

Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC

Purpose: Neoadjuvant therapy (NAT) is considered the standard of care for patients with HER2-positive breast cancer (BC). However, there is no proven survival benefit of NAT compared to adjuvant therapy for the survival of patients with early-stage HER2-positive BC. This study aimed to compare the p...

Fuld beskrivelse

Na minha lista:
Principais autores: Shuyue Zheng, Lun Li, Ming Chen, Benlong Yang, Jiajian Chen, Guangyu Liu, Zhimin Shao, Jiong Wu
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2022-06-01
Serier:Breast
Fag:
HER2-positive breast cancer
Neoadjuvant therapy
Adjuvant therapy
Survival outcomes
Online adgang:http://www.sciencedirect.com/science/article/pii/S0960977622000698
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker